Development of Eurasian H7N7/PR8 high growth reassortant virus for clinical evaluation as an inactivated pandemic influenza vaccine.

Jadhao, Samadhan J

Development of Eurasian H7N7/PR8 high growth reassortant virus for clinical evaluation as an inactivated pandemic influenza vaccine. [electronic resource] - Vaccine Mar 2008 - 1742-50 p. digital

Publication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.

0264-410X

10.1016/j.vaccine.2008.01.036 doi


Animals
Antibodies, Viral--analysis
Antibody Specificity
Cross Reactions
Disease Outbreaks--prevention & control
Ferrets
Humans
Influenza A Virus, H7N7 Subtype--growth & development
Influenza Vaccines--immunology
Influenza, Human--immunology
Mice
Models, Molecular
Phenotype
Reassortant Viruses--growth & development
Vaccines, Inactivated--immunology